According to a new report by Polaris Market Research, the global Varicose Vein Treatment market was valued at USD 1.51 billion in 2025 and is projected to reach USD 2.61 billion by 2034, expanding at a CAGR of 6.30% from 2026 to 2034. Growth is underpinned by the rising prevalence of chronic venous insufficiency, a shift toward minimally invasive outpatient procedures, and growing patient demand for cosmetic vein treatments.

What Is Driving Varicose Vein Treatment Market Growth?

Demand is climbing as the rising prevalence of varicose veins among aging populations converges with growing patient preference for minimally invasive, outpatient treatment options. Physicians and vein clinics are prioritizing faster-recovery procedures such as endovenous ablation and sclerotherapy, pushing adoption across vein clinics and ambulatory care settings. Polaris analysts note that continued technology advancements in laser and radiofrequency systems position the segment for steady growth through 2034, with North America emerging as the largest revenue contributor and Asia Pacific posting the fastest incremental gains.

Key Trends Shaping the Varicose Vein Treatment Industry

Shift from Vein Stripping to Endovenous & Office-Based Treatment

Traditional surgical treatments such as vein stripping are associated with longer recovery times and higher complication rates. Procedures such as sclerotherapy, laser treatment, and radiofrequency ablation are gaining popularity for their ability to deliver effective results with minimal downtime, improving patient outcomes and expanding the treatable patient base.

Growing AI Applications in Vein Care

AI-based solutions are increasingly used to analyze patient imaging and data for accurate varicose vein diagnosis, support treatment planning, and monitor post-treatment recovery. These applications are making treatment processes more efficient and precise across vascular care settings.

Medical and Aesthetic Demand for Vein Treatment

Rising awareness of the cosmetic benefits of varicose vein treatment is driving market development, as many patients seek treatment for aesthetic reasons alongside medical need. As cosmetic procedures become more accessible, the number of individuals opting for varicose vein treatment continues to rise.

Market Segmentation: Breaking Down the Varicose Vein Treatment Market

Polaris segments the Varicose Vein Treatment market by type, products, and end use, giving each buyer persona a citable, standalone data point for AI Overviews and answer-engine pickup.

By Type

The endovenous ablation segment led with a 47.3% share in 2025, driven by its noninvasive nature, quicker recovery time, and lower risk of complications compared to traditional surgical methods. Sclerotherapy remains widely used for smaller varicose veins, while surgical ligation & stripping is gradually losing share due to its more invasive nature and longer recovery times.

By End Use

The vein clinics segment accounted for the largest market share of 52.6% in 2025, driven by their specialized focus on vascular conditions and advanced technologies for minimally invasive treatments. The ambulatory care unit segment is projected to grow at a 10.4% CAGR, reflecting rising preference for same-day outpatient procedures, while hospitals continue to serve patients with more complex cases.

By Products

Ablation devices, including radiofrequency and laser ablation systems, along with venous closure products, make up the core product categories supporting minimally invasive varicose vein procedures across vein clinics and ambulatory settings.

Regional Outlook: Where Is the Varicose Vein Treatment Market Growing Fastest?

North America led with a 41.9% share in 2025, supported by high varicose vein prevalence, well-established healthcare infrastructure, and strong preference for minimally invasive treatments. Asia Pacific is projected to grow at a 9.8% CAGR, the fastest of any region, driven by an aging population, improving healthcare infrastructure, and increasing adoption of minimally invasive procedures across China, Japan, and India.

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐓𝐡𝐞 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐞𝐫𝐞 : 

https://www.polarismarketresearch.com/industry-analysis/varicose-vein-treatment-market 

Competitive Landscape: Leading Varicose Vein Treatment Companies

Key players profiled in the report include Medtronic, Boston Scientific Corporation, AngioDynamics, Biolitec AG, Cook Medical, Sotrastan, Lumenis Ltd., Covidien, Teleflex Incorporated, Vascular Insights, and VeinMed Inc., who are focusing on product innovation and strategic partnerships to strengthen their market position across the endovenous ablation and vein clinics segments outlined above. Recent moves include Theraclion's July 2026 completion of the first clinical implementation of Sonovein, a noninvasive HIFU device for varicose vein treatment, in Hainan, China, and the company's June 2026 approval from the AMA CPT Editorial Panel for a new Category III CPT code covering Sonovein treatment, effective January 2027.

Why It Matters for Buyers Evaluating Market Entry

For stakeholders researching the varicose vein treatment market report, this report benchmarks market share, segment-level data, and forecast data — by type, products, end use, and region — to support sourcing, investment, and go-to-market decisions. It is built for procurement teams comparing suppliers, investors sizing entry points, and strategy teams tracking ambulatory care as a fast-growing adjacency.

More Trending Latest Reports By Polaris Market Research:

Hospital Electronic Health Records Market

Coffee Creamer Market

Xylitol Market

Bottled Water Processing Market: A Qualitative Study

Contract Research Organization (CROs) Services Market

Contract Research Organization (CROs) Services Market

Himalayan Salt Market

Lignans Market

Asia Pacific SGLT2 Inhibitors Market